Precision Medicine: Who Captures the Value?
8 July 2026.Precision medicine shifts value from therapies to diagnostics, evidence and access
Precision medicine shifts value from therapies to diagnostics, evidence and access
The global cell & gene therapy manufacturing market is valued at US$13.7 billion in 2026
Healthcare moves home as pharma’s commercial model shifts toward patients
Patient persistence is becoming pharma’s next growth test after launch
Prevention-led pharma growth depends on earlier intervention, access and scale
Healthcare growth is shifting from standard treatments to personalised patient strategies
Women’s health trials enter a more evidence-led, higher-value growth phase
The global Women’s Clinical Trials & CROs Market is projected to grow at a CAGR of 8.5% by 2036
Vaccines are shifting from prevention into platforms, oncology and manufacturing-led growth
The global Vaccine Sales market is projected to grow at a CAGR of 6.3% by 2036
Pre-filled syringes shift from convenience to strategic biologics delivery platform
The global Pre-Filled Syringes market is projected to grow at a CAGR of 9.2% by 2036
mRNA vaccine platforms expand beyond prevention into oncology and immune-mediated diseases
Pharma distribution becomes strategic as speciality medicines reshape access and infrastructure
IoMT is reshaping healthcare through AI, wearables and connected care.
CDMOs become strategic partners as biologics complexity reshapes pharmaceutical manufacturing
Pharmaceutical packaging is becoming strategic, smarter, sustainable and growth-critical
Contract manufacturing set for strong growth as biologics outsourcing expands
Pharma packaging demand rises as biologics, safety and traceability pressures grow
The global mRNA Cancer Vaccine market is projected to grow at a CAGR of 27.1% by 2036